ironSource Announces Record First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Outlook Therapeutics (OTLK) halted, news pending
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
Day One Biopharmaceuticals (DAWN) and ironSource (IS) Removed from Wedbush Best Ideas List
May 13, 2022 7:13 AM EDTDay One Biopharmaceuticals (NASDAQ: DAWN) and ironSource Ltd. (NYSE: IS) Removed from Wedbush Best Ideas List
... MoreironSource Ltd. (IS) Tops Q1 EPS by 2c
May 12, 2022 7:34 AM EDTironSource Ltd. (NYSE: IS) reported Q1 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $190 million versus the consensus estimate of $183.71 million.
GUIDANCE:
ironSource Ltd. sees Q2 2022 revenue of $750-780 million.
For earnings history and earnings-related data on ironSource Ltd. (IS) click here.
... More